Displaying 901 - 950 of 5089 results
Released Company Title Industry Topic
23 Sep 2024
07:00 CEST
MAGNORA Magnora ASA: Repurchase of shares 60102020 Renewable Energy Equipment Acquisition or disposal of the issuer’s own shares
23 Sep 2024
07:00 CEST
INNATE PHARMA Innate Pharma reçoit l’autorisation de l’agence américaine du médicament d’initier le développement clinique d’IPH4502, son ADC ciblant Nectine-4, dans les tumeurs solides 20103010 Biotechnology Products and services
23 Sep 2024
07:00 CEST
INNATE PHARMA Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors 20103010 Biotechnology Products and services
23 Sep 2024
07:00 CEST
AQUILA HOLDINGS ASA Aquila Holdings share buyback program status 60101030 Oil Equipment and Services Additional regulated information required to be disclosed under the laws of a Member State
22 Sep 2024
20:38 CEST
KITRON Kitron revises outlook for second half 2024 50202040 Electronic Equipment: Other Inside information
22 Sep 2024
20:38 CEST
KITRON Kitron justerer utsiktene for andre halvår 2024 50202040 Electronic Equipment: Other Innsideinformasjon
21 Sep 2024
09:21 CEST
BERNARD LOISEAU Rapport semestriel Bernard Loiseau 2024 40501040 Restaurants and Bars Commercial results
21 Sep 2024
09:13 CEST
BERNARD LOISEAU Communiqué sur les comptes semestriels Bernard Loiseau SA 2024 40501040 Restaurants and Bars Commercial results
21 Sep 2024
03:47 CEST
OTELLO CORPORATION Otello Corporation share buyback program status 10101020 Consumer Digital Services Acquisition or disposal of the issuer’s own shares
21 Sep 2024
00:36 CEST
SANOFI Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué (...) 20103015 Pharmaceuticals Other subject
21 Sep 2024
00:36 CEST
SANOFI Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant 20103015 Pharmaceuticals Other subject
20 Sep 2024
22:58 CEST
FREELANCE.COM Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023 10101020 Consumer Digital Services Income
20 Sep 2024
22:34 CEST
ENSURGE MICROPOWER ASA Ensurge is publishing a new research report on our homepage 50202040 Electronic Equipment: Other Non-regulatory press releases
20 Sep 2024
22:00 CEST
ALTERNUS ENERGY GROUP PLC Affiliate Alternus Clean Energy Inc. Notice 65101010 Alternative Electricity Non-regulatory press releases
20 Sep 2024
21:14 CEST
POLARIS MEDIA Polaris Media ASA (POL) - Salg av egne aksjer 40301030 Publishing Utsteders meldeplikt ved handel i egne aksjer
20 Sep 2024
21:05 CEST
CLARIANE SE Clariane intègre l’indice CAC® SBT 1.5° 20101010 Health Care Facilities Other subject
20 Sep 2024
21:05 CEST
CLARIANE SE Clariane announces its entry into the CAC® SBT 1.5° 20101010 Health Care Facilities Other subject
20 Sep 2024
19:45 CEST
ONWARD MEDICAL ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris 20101025 Health Services -
20 Sep 2024
19:36 CEST
NACON COMMUNIQUE DE PRESSE: NACON: Emission d’actions nouvelles dans le cadre de l’acquisition de Big Ant Studios 40203040 Electronic Entertainment Share history
20 Sep 2024
19:36 CEST
NACON PRESS RELEASE: NACON: ISSUANCE OF NEW SHARES IN CONNECTION WITH THE ACQUISITION OF BIG ANT STUDIOS 40203040 Electronic Entertainment Share history
20 Sep 2024
19:30 CEST
NACON NACON: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social 40203040 Electronic Entertainment Share history
20 Sep 2024
19:09 CEST
AMUNDI Half-Year Financial Report as of 30 June 2024 available 30202010 Asset Managers and Custodians Corporate life
20 Sep 2024
19:09 CEST
AMUNDI Mise à disposition du Rapport Financier Semestriel au 30 juin 2024 30202010 Asset Managers and Custodians Corporate life
20 Sep 2024
18:45 CEST
VIVENDI SE Vivendi: Canal+’s New Perimeter and Reporting Segments 40301035 Radio and TV Broadcasters Other financial transaction
20 Sep 2024
18:45 CEST
VIVENDI SE Vivendi : nouveau périmètre de Canal+ et segments d’activité 40301035 Radio and TV Broadcasters Other financial transaction
20 Sep 2024
18:36 CEST
SHELL PLC Transaction in Own Shares 60101000 Integrated Oil and Gas Other subject
20 Sep 2024
18:30 CEST
FIPP FIPP : Communiqué sur les résultats semestriels au 30 juin 2024 30202000 Diversified Financial Services Income
20 Sep 2024
18:30 CEST
VIEL ET COMPAGNIE VIEL & Cie : Mise à disposition du rapport financier semestriel au 30 juin 2024 30202015 Investment Services Other subject
20 Sep 2024
18:30 CEST
NOVACYT Confirmation de la règle 19.6(c) relative aux déclarations d'intention post-offre faites en relation avec Yourgene Health plc 20102010 Medical Equipment Legal
20 Sep 2024
18:30 CEST
FONCIERE 7 INVEST FONCIERE 7 INVESTISSEMENT/ COMMUNIQUE DE MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2024 50202010 Electrical Components Income
20 Sep 2024
18:02 CEST
B.C.P.-BCO COMERCIAL PORTUGUES Banco Comercial Português, S.A. informs about the ruling of the Competition, Regulation and Supervision Court 30101010 Banks Other subject
20 Sep 2024
18:02 CEST
B.C.P.-BCO COMERCIAL PORTUGUES Banco Comercial Português, S.A. informa sobre a decisão do Tribunal da Concorrência, Regulação e Supervisão 30101010 Banks Other subject
20 Sep 2024
18:00 CEST
JACQUET METALS JACQUET METALS SA : PROGRAMME DE RACHAT DE TITRES 55102010 Iron and Steel Corporate life
20 Sep 2024
18:00 CEST
ADOCIA ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 août 2024 20103010 Biotechnology Other subject
20 Sep 2024
18:00 CEST
FORSEE POWER Forsee Power: Strong First-half Financial Performance in a Fast-changing Market 50202010 Electrical Components Sales
20 Sep 2024
18:00 CEST
IT LINK IT Link : 2,92 M€ de résultat opérationnel au premier semestre 2024 10101010 Computer Services Income
20 Sep 2024
18:00 CEST
FORSEE POWER Forsee Power : très bonnes performances financières semestrielles dans un marché en pleine évolution 50202010 Electrical Components Sales
20 Sep 2024
18:00 CEST
ADOCIA Number of Shares and Voting Rights of ADOCIA as of August 31st, 2024 20103010 Biotechnology Other subject
20 Sep 2024
18:00 CEST
NEOLIFE NEOLIFE annonce son résultat semestriel 2024 50101035 Building Materials: Other -
20 Sep 2024
18:00 CEST
AUREA Bilan semestriel au 30/06/2024 du contrat de liquidité AUREA 65103035 Waste and Disposal Services Share history
20 Sep 2024
17:58 CEST
EQVA ASA EQVA ASA: Granting of share options 50206030 Marine Transportation Additional regulated information required to be disclosed under the laws of a Member State
20 Sep 2024
17:45 CEST
SAFRAN Safran - Share buyback for cancellation 50201010 Aerospace Other subject
20 Sep 2024
17:45 CEST
NACON NACON: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social 40203040 Electronic Entertainment Share history
20 Sep 2024
17:45 CEST
RENAULT Information relating to the total number of voting rights and share capital - August 31, 2024 40101020 Automobiles Other subject
20 Sep 2024
17:45 CEST
SAFRAN Safran - Rachat d’actions pour annulation 50201010 Aerospace Other subject
20 Sep 2024
17:45 CEST
RENAULT Information relative au nombre total de droits de vote et de capital - 31 août 2024 40101020 Automobiles Other subject
20 Sep 2024
17:44 CEST
ARCTIC FISH HOLDING AS Financial calendar 45102010 Farming, Fishing, Ranching and Plantations Additional regulated information required to be disclosed under the laws of a Member State
20 Sep 2024
17:40 CEST
ALTEN Mise à disposition du Rapport Financier Semestriel 2024 10101010 Computer Services Legal
20 Sep 2024
17:40 CEST
AGEAS Ageas et Amundi SA: Notification de transparence 30301010 Life Insurance Other financial transaction
20 Sep 2024
17:40 CEST
ALTEN Availability of the 2024 Half-Year Financial Report 10101010 Computer Services Legal